Dimensional Fund Advisors
CGON icon

Dimensional Fund Advisors’s CG Oncology CGON Stock Holding History

Dimensional Fund Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8M Sell
433,882
-4,791
-1% -$313K 0.01% 1839
2026
Q1 		$29.7M Sell
438,673
-22,459
-5% -$1.27M 0.01% 1774
2025
Q4 		$19.1M Buy
461,132
+8,781
+2% +$363K ﹤0.01% 1985
2025
Q3 		$18.2M Buy
452,351
+193,140
+75% +$5.62M ﹤0.01% 2033
2025
Q2 		$6.74M Buy
259,211
+227,053
+706% +$5.47M ﹤0.01% 2431
2025
Q1 		$788K Buy
+32,158
New +$905K ﹤0.01% 2924

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's CGON Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its CG Oncology (CGON) stake by 1.1% in Q2 2026, selling an estimated $313K and leaving 433,882 shares worth $30.8M. The position accounts for 0.01% of the portfolio, ranked #1839.

Dimensional Fund Advisors first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Dimensional Fund Advisors held 433,882 shares of CG Oncology worth $30.8M as of Q2 2026.
  • Dimensional Fund Advisors sold 4,791 CG Oncology shares in Q2 2026, an estimated $313K.
  • CG Oncology made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1839 holding.
  • Dimensional Fund Advisors first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.